EVALUATE & REVIEW

• Program

• Target

• Non-clinical/Clinical pipeline

• Indications

• Novel/existing MOA approaches

• IP position

• IP and FTO searches

PLAN & EXECUTE

• Full program budgeting

• Screening cascade design 

• Building effective R&D teams 

• Hit ID

• Hit to Lead

• Lead Optimization

• SAR analysis, multiparameter

• Rational drug design (structurally enabled)

• Fragment Based Drug Discovery

• Custom assay design

• Planning and assessing target validation